Norland’s Paris scanner hits market

Article

Bone densitometry firm Norland Medical Systems continues to make progress in rolling out its Paris ultrasound bone measurement system. The company has begun delivery of Paris systems to European and Pacific Rim customers, and is shipping Paris to

Bone densitometry firm Norland Medical Systems continues to make progress in rolling out its Paris ultrasound bone measurement system. The company has begun delivery of Paris systems to European and Pacific Rim customers, and is shipping Paris to physician investigators for testing as part of the Food and Drug Administration's premarket approval process. Norland expects to file its PMA this quarter.

In other company news, Norland has received FDA 510(k) clearance to market a fracture risk assessment feature for its pDEXA x-ray peripheral bone densitometer. Physicians can use the feature to select patients who might benefit from preventive treatment to avoid fractures, as well as to make clinical decisions regarding therapeutic intervention, according to White Plains, NY-based Norland.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.